{"id":15066,"date":"2022-12-05T15:21:36","date_gmt":"2022-12-05T20:21:36","guid":{"rendered":"https:\/\/innovativemedicines.ca\/newsroom\/all-news\/"},"modified":"2022-12-05T16:04:41","modified_gmt":"2022-12-05T21:04:41","slug":"mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/","title":{"rendered":"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB"},"content":{"rendered":"\n<p><strong>Ottawa, Ont.<\/strong> \u2013 M\u00e9dicaments novateurs Canada (MNC) a soumis <a href=\"https:\/\/innovativemedicines.ca\/resources\/all-resources\/suspension-reformulation-pmprb-guidelines-urgently-required-imc-response-pmprb-2022-guidelines-proposals\/\" target=\"_blank\" rel=\"noreferrer noopener\">une r\u00e9troaction officielle<\/a> \u00e0 la consultation publique des Lignes directrices provisoires r\u00e9vis\u00e9es du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB), demandant la suspension de la mise en \u0153uvre pr\u00e9vue afin d\u2019assurer une consultation s\u00e9rieuse des parties prenantes et une analyse approfondie des r\u00e9percussions.<\/p>\n\n\n\n<p>Les Lignes directrices provisoires propos\u00e9es, telles qu\u2019elles sont r\u00e9dig\u00e9es actuellement, ne feront que r\u00e9duire davantage l\u2019acc\u00e8s aux nouveaux m\u00e9dicaments, traitements et essais cliniques pour les Canadiens, en plus de compromettre le succ\u00e8s d\u2019autres priorit\u00e9s gouvernementales comme la strat\u00e9gie nationale sur les m\u00e9dicaments pour le traitement des maladies rares et la strat\u00e9gie en mati\u00e8re de biofabrication et de sciences de la vie.<\/p>\n\n\n\n<p>L\u2019acc\u00e8s rapide aux nouveaux m\u00e9dicaments sauve des vies, r\u00e9duit les co\u00fbts des soins de sant\u00e9, contribue \u00e0 la productivit\u00e9 \u00e9conomique et fait du Canada une destination attrayante pour les investissements et le lancement de nouveaux m\u00e9dicaments. Actuellement, seuls 18 % des nouveaux m\u00e9dicaments lanc\u00e9s dans le monde sont accessibles aux Canadiens via les r\u00e9gimes publics d\u2019assurance m\u00e9dicaments.<\/p>\n\n\n\n<p>La suspension des Lignes directrices provisoires actuelles du CEPMB nous permettra \u2013 ensemble \u2013 de tracer une meilleure voie, d\u2019en choisir une qui place les patients au centre de nos syst\u00e8mes de soins de sant\u00e9 et qui encourage les investissements futurs au Canada.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">\u00c0 propos de M\u00e9dicaments novateurs Canada<\/h5>\n\n\n\n<p>M\u00e9dicaments novateurs Canada (MNC) est l\u2019association nationale qui repr\u00e9sente la voix de l\u2019industrie pharmaceutique innovatrice canadienne. L\u2019association d\u00e9fend des politiques qui favorisent la d\u00e9couverte, le d\u00e9veloppement et l\u2019offre de m\u00e9dicaments et de vaccins novateurs afin d\u2019am\u00e9liorer la vie de l\u2019ensemble de la population. De plus, elle soutient l\u2019engagement de ses membres d\u2019\u00eatre des partenaires pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. L\u2019association repr\u00e9sente 50 entreprises, qui investissent pr\u00e8s de 1,4 milliard de dollars par an en recherche et d\u00e9veloppement. De cette fa\u00e7on, elle alimente l\u2019\u00e9conomie fond\u00e9e sur la connaissance du pays tout en contribuant \u00e0 hauteur de 8 milliards de dollars \u00e0 l\u2019\u00e9conomie nationale. Tous ses membres suivent le Code d\u2019\u00e9thique de MNC, ils travaillent donc de mani\u00e8re hautement \u00e9thique avec les gouvernements, les payeurs priv\u00e9s, les professionnels de la sant\u00e9 et les parties prenantes.<\/p>\n\n\n\n<p class=\"has-text-align-center\">\u2013 30 \u2013<\/p>\n\n\n\n<p>Pour de plus amples renseignements :<\/p>\n\n\n\n<p>Marise Varanda<br \/>Directrice, Relations avec les m\u00e9dias et contenu<br \/>T\u00e9l\u00e9phone : 613-462-5367<br \/>Courriel : <a href=\"mailto:media@imc-mnc.ca\">media@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ottawa, Ont. \u2013 M\u00e9dicaments novateurs Canada (MNC) a soumis une r\u00e9troaction officielle \u00e0 la consultation publique des Lignes directrices provisoires [&hellip;]<\/p>\n","protected":false},"featured_media":15070,"template":"","topic":[245,209],"team-member-id":[],"news-category":[176,4],"news-tag":[],"class_list":["post-15066","news","type-news","status-publish","has-post-thumbnail","hentry","topic-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb","topic-patented-medicine-prices-review-board-pmprb","news-category-communique","news-category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Ottawa, Ont. \u2013 M\u00e9dicaments novateurs Canada (MNC) a soumis une r\u00e9troaction officielle \u00e0 la consultation publique des Lignes directrices provisoires [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-05T21:04:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1980\" \/>\n\t<meta property=\"og:image:height\" content=\"1320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/\",\"name\":\"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg\",\"datePublished\":\"2022-12-05T20:21:36+00:00\",\"dateModified\":\"2022-12-05T21:04:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#primaryimage\",\"url\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg\",\"contentUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg\",\"width\":1980,\"height\":1320,\"caption\":\"Rear view of son and elderly father sitting together at home. Son caring for his father, putting hand on his shoulder, comforting and consoling him. Family love, bonding, care and confidence\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/","og_locale":"fr_FR","og_type":"article","og_title":"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada","og_description":"Ottawa, Ont. \u2013 M\u00e9dicaments novateurs Canada (MNC) a soumis une r\u00e9troaction officielle \u00e0 la consultation publique des Lignes directrices provisoires [&hellip;]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2022-12-05T21:04:41+00:00","og_image":[{"width":1980,"height":1320,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/","name":"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg","datePublished":"2022-12-05T20:21:36+00:00","dateModified":"2022-12-05T21:04:41+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-1349214017-scaled.jpg","width":1980,"height":1320,"caption":"Rear view of son and elderly father sitting together at home. Son caring for his father, putting hand on his shoulder, comforting and consoling him. Family love, bonding, care and confidence"},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-demande-suspension-lignes-directrices-provisoires-revisees-cepmb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/"},{"@type":"ListItem","position":4,"name":"M\u00e9dicaments novateurs Canada demande la suspension des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/15066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/15070"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=15066"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=15066"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=15066"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=15066"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=15066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}